All Stories

  1. Cuneus atrophy and Parkinsonian phenoconversion in cognitively unimpaired patients with isolated REM sleep behavior disorder

    Article • Journal of Neurology, December 2024, Springer Science + Business Media

    Dr Per Borghammer

  2. Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion

    Article • European Journal of Neurology, October 2024, Wiley

    Dr Per Borghammer

  3. Correlation between dopaminergic and metabolic asymmetry in Lewy body disease – A dual-imaging study

    Article • Parkinsonism & Related Disorders, October 2024, Elsevier

    Dr Per Borghammer

  4. Approaches to Early Parkinson’s Disease Subtyping

    Article • Journal of Parkinson’s Disease, October 2024, IOS Press

    Dr Per Borghammer

  5. Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”

    Article • Journal of Parkinson’s Disease, July 2024, IOS Press

    Dr Per Borghammer

  6. Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

    Article • npj Parkinson s Disease, June 2024, Springer Science + Business Media

    Dr Per Borghammer

  7. Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same

    Article • Journal of Parkinson’s Disease, April 2024, IOS Press

    Dr Per Borghammer

  8. The Body, the Brain, the Environment, and Parkinson’s Disease

    Article • Journal of Parkinson’s Disease, April 2024, IOS Press

    Dr Per Borghammer

  9. Functional and 123I-MIBG scintigraphy assessment of cardiac adrenergic dysfunction in diabetes

    Article • Autonomic Neuroscience, April 2024, Elsevier

    Dr Per Borghammer

  10. Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder

    Article • Movement Disorders, March 2024, Wiley

    Dr Per Borghammer

  11. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease

    Article • Acta Neuropathologica, March 2024, Springer Science + Business Media

    Dr Per Borghammer

  12. Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes

    Article • Brain, March 2024, Oxford University Press (OUP)

    Dr Per Borghammer

  13. Brain-first vs. body-first Parkinson's disease: An update on recent evidence

    Article • Parkinsonism & Related Disorders, March 2024, Elsevier

    Dr Per Borghammer

  14. Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodies

    Article • Brain, November 2023, Oxford University Press (OUP)

    Dr Per Borghammer

  15. STING activation counters glioblastoma by vascular alteration and immune surveillance

    Article • Cancer Letters, November 2023, Elsevier

    Dr Per Borghammer

  16. Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder

    Article • European Journal of Neurology, October 2023, Wiley

    Dr Per Borghammer

  17. Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies

    Article • Brain, June 2023, Oxford University Press (OUP)

    Dr Per Borghammer

  18. Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism

    Article • EJNMMI Research, May 2023, Springer Science + Business Media

    Dr Per Borghammer

  19. Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson’s Disease

    Article • Journal of Parkinson’s Disease, May 2023, IOS Press

    Dr Per Borghammer

  20. The heterogeneity of Parkinson’s disease

    Article • Acta Neurovegetativa, May 2023, Springer Science + Business Media

    Dr Per Borghammer

  21. The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models

    Article • Acta Neurovegetativa, April 2023, Springer Science + Business Media

    Dr Per Borghammer

  22. Distribution of cholinergic nerve terminals in the aged human brain measured with [18F]FEOBV PET and its correlation with histological data

    Article • NeuroImage, April 2023, Elsevier

    Dr Per Borghammer

  23. Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases : An [ 11 C ] UCB‐J ...

    Article • Movement Disorders, March 2023, Wiley

    Dr Per Borghammer

  24. Thyroid [123I]MIBG uptake in Parkinson’s disease and diabetes mellitus

    Article • IBRO Neuroscience Reports, March 2023, Elsevier

    Dr Per Borghammer

  25. Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies

    Article • Brain, February 2023, Oxford University Press (OUP)

    Dr Per Borghammer

  26. Cholinergic Imaging and Dementia

    Article • January 2023, Springer Science + Business Media

    Dr Per Borghammer

  27. Disruption of Sleep Microarchitecture Is a Sensitive and Early Marker of Parkinson’s Disease

    Article • Journal of Parkinson’s Disease, December 2022, IOS Press

    Dr Per Borghammer

  28. Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study

    Article • Journal of Parkinson’s Disease, December 2022, IOS Press

    Dr Per Borghammer, Jacob Horsager

  29. RBDtector: an open-source software to detect REM sleep without atonia according to visual scoring criteria

    Article • Scientific Reports, December 2022, Springer Science + Business Media

    Dr Per Borghammer

  30. Revisiting the Dual-Hit Hypothesis: Insights from Postmortem Studies in Parkinson's Disease

    Article • npj Parkinson s Disease, November 2022, Springer Science + Business Media

    Dr Per Borghammer

  31. [18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson's disease

    Article • Parkinsonism & Related Disorders, November 2022, Elsevier

    Dr Per Borghammer

  32. Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET

    Article • Nuclear Medicine and Biology, September 2022, Elsevier

    Dr Per Borghammer

  33. Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up

    Article • Parkinsonism & Related Disorders, August 2022, Elsevier

    Dr Per Borghammer

  34. Spinal cord stimulation therapy for patients with Parkinson’s disease and gait problems (STEP-PD): study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial

    Article • BMJ Neurology Open, August 2022, BMJ

    Dr Per Borghammer

  35. Impact of aging on animal models of Parkinson's disease

    Article • Frontiers in Aging Neuroscience, July 2022, Frontiers

    Dr Per Borghammer

  36. Intestinal Transit in Early Moderate Parkinson’s Disease Correlates with Probable RBD: Subclinical Esophageal Dysmotility Does Not Correlate

    Article • Parkinson s Disease, July 2022, Hindawi Publishing Corporation

    Dr Per Borghammer

  37. Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies

    Article • Frontiers in Aging Neuroscience, May 2022, Frontiers

    Dr Per Borghammer

  38. Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression

    Article • Brain, May 2022, Oxford University Press (OUP)

    Dr Per Borghammer

  39. In vivo vesicular acetylcholine transporter density in human peripheral organs: an [18F]FEOBV PET/CT study

    Article • EJNMMI Research, April 2022, Springer Science + Business Media

    Dr Per Borghammer

  40. Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

    Article • The Lancet Neurology, February 2022, Elsevier

    Dr Per Borghammer

  41. Passive Immunization in Alpha-Synuclein Preclinical Animal Models

    Article • Biomolecules, January 2022, MDPI AG

    Dr Per Borghammer

  42. Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study

    Article • Aging Brain, January 2022, Elsevier

    Dr Per Borghammer

  43. Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Dr Per Borghammer

  44. Neuropathological evidence of body-first vs. brain-first Lewy body disease

    Article • Neurobiology of Disease, December 2021, Elsevier

    Dr Per Borghammer

  45. Long-term Risk of Parkinson Disease Following Influenza and Other Infections

    Article • JAMA Neurology, October 2021, American Medical Association (AMA)

    Dr Per Borghammer

  46. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson’s Disease Subtypes

    Article • Journal of Parkinson’s Disease, October 2021, IOS Press

    Dr Per Borghammer

  47. Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson’s Disease: A Longitudinal Analysis of Two International Cohorts

    Article • Journal of Parkinson’s Disease, August 2021, IOS Press

    Dr Per Borghammer

  48. Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy

    Article • Journal of Neurogastroenterology and Motility, July 2021, The Korean Society of Neurogastroenterology and Motility

    Dr Per Borghammer

  49. Radionuclide imaging of the gut-brain axis in Parkinson’s disease

    Article • Journal of Nuclear Medicine, July 2021, Society of Nuclear Medicine

    Dr Per Borghammer

  50. Cortical Activity During an Attack of Ménière's Disease—A Case Report

    Article • Frontiers in Neurology, July 2021, Frontiers

    Dr Per Borghammer

  51. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson’s disease

    Article • Brain, July 2021, Oxford University Press (OUP)

    Dr Per Borghammer

  52. Vagus Nerve Cross-Sectional Area in Patients With Parkinson's Disease—An Ultrasound Case-Control Study

    Article • Frontiers in Neurology, June 2021, Frontiers

    Dr Per Borghammer

  53. Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease

    Article • npj Parkinson s Disease, June 2021, Springer Science + Business Media

    Dr Per Borghammer

  54. Fasting gallbladder volume is increased in patients with Parkinson's disease

    Article • Parkinsonism & Related Disorders, June 2021, Elsevier

    Dr Per Borghammer

  55. Preserved noradrenergic function in Parkinson's disease patients with rest tremor

    Article • Neurobiology of Disease, May 2021, Elsevier

    Dr Per Borghammer

  56. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ 11 C ] UCB‐J PET Imaging Study

    Article • Movement Disorders, April 2021, Wiley

    Dr Per Borghammer

  57. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats

    Article • Brain, April 2021, Oxford University Press (OUP)

    Dr Per Borghammer

  58. Prodromal Parkinson disease subtypes — key to understanding heterogeneity

    Article • Nature Reviews Neurology, April 2021, Springer Science + Business Media

    Dr Per Borghammer

  59. Impaired cerebral microcirculation in isolated REM sleep behaviour disorder

    Article • Brain, April 2021, Oxford University Press (OUP)

    Dr Per Borghammer

  60. The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

    Article • Journal of Parkinson’s Disease, April 2021, IOS Press

    Dr Per Borghammer

  61. Asymmetric Distribution of Dopamine Transporters in Premorbid Corticobasal Syndrome—A Case Report

    Article • Movement Disorders Clinical Practice, April 2021, Wiley

    Dr Per Borghammer

  62. Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives

    Article • Journal of Clinical Medicine, March 2021, MDPI AG

    Dr Per Borghammer

  63. Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder

    Article • Proceedings of the National Academy of Sciences, March 2021, Proceedings of the National Academy of Sciences

    Dr Per Borghammer

  64. The Logic and Pitfalls of Parkinson's as Brain‐ Versus Body‐First Subtypes

    Article • Movement Disorders, March 2021, Wiley

    Dr Per Borghammer

  65. Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson’s disease

    Article • SLEEP, February 2021, Oxford University Press (OUP)

    Dr Per Borghammer

  66. Cognitive impairment in Parkinson's disease is associated with Default Mode Network subsystem connectivity and cerebrospinal fluid Aβ

    Article • Parkinsonism & Related Disorders, February 2021, Elsevier

    Dr Per Borghammer

  67. Gastrointestinal Dysfunction in Parkinson’s Disease

    Article • Journal of Clinical Medicine, January 2021, MDPI AG

    Dr Per Borghammer

  68. Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder

    Article • Parkinsonism & Related Disorders, December 2020, Elsevier

    Dr Per Borghammer

  69. Abstract

    Article • Movement Disorders, September 2020, Wiley

    Dr Per Borghammer

  70. Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study

    Article • Brain, August 2020, Oxford University Press (OUP)

    Dr Per Borghammer

  71. Absent 18F-FDG Uptake in the Brain—Unsuspected Brain Death

    Article • Clinical Nuclear Medicine, August 2020, Wolters Kluwer Health

    Dr Per Borghammer

  72. Skin Temperature in Parkinson’s Disease Measured by Infrared Thermography

    Article • Parkinson s Disease, July 2020, Hindawi Publishing Corporation

    Dr Per Borghammer

  73. Colonic motility in patients with type 1 diabetes and gastrointestinal symptoms

    Article • Neurogastroenterology & Motility, July 2020, Wiley

    Dr Per Borghammer

  74. Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder – A PET study

    Article • Parkinsonism & Related Disorders, June 2020, Elsevier

    Dr Per Borghammer

  75. A Screening-Based Method for Identifying Patients with REM Sleep Behaviour Disorder in a Danish Community Setting

    Article • Journal of Parkinson’s Disease, May 2020, IOS Press

    Dr Per Borghammer

  76. Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers

    Article • Journal of Neurology, April 2020, Springer Science + Business Media

    Dr Per Borghammer

  77. Applied strategy in the Iowa Gambling Task: Comparison of individuals with Parkinson’s disease to healthy controls

    Article • Journal of Clinical and Experimental Neuropsychology, April 2020, Taylor & Francis

    Malene Flensborg Damholdt, Dr Per Borghammer

  78. Normative values for gastric motility assessed with the 3D‐transit electromagnetic tracking system

    Article • Neurogastroenterology & Motility, March 2020, Wiley

    Dr Per Borghammer

  79. PET Visualized Stimulation of the Vestibular Organ in Menière's Disease

    Article • Frontiers in Neurology, January 2020, Frontiers

    Dr Per Borghammer

  80. Tau Tangles in Parkinson’s Disease: A 2-Year Follow-Up Flortaucipir PET Study

    Article • Journal of Parkinson’s Disease, January 2020, IOS Press

    Dr Per Borghammer

  81. Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder

    Article • European Journal of Neurology, December 2019, Wiley

    Dr Per Borghammer

  82. In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients

    Article • Neurogastroenterology & Motility, November 2019, Wiley

    Dr Per Borghammer

  83. Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis

    Article • Journal of Parkinson’s Disease, October 2019, IOS Press

    Dr Per Borghammer

  84. Enteric cholinergic neuropathy in patients with diabetes: Non‐invasive assessment with positron emission tomography

    Article • Neurogastroenterology & Motility, October 2019, Wiley

    Dr Per Borghammer

  85. Normative values for region‐specific colonic and gastrointestinal transit times in 111 healthy volunteers using the 3D‐Transit electromagnet tracking system: Influence of age, gender, and body mass index

    Article • Neurogastroenterology & Motility, September 2019, Wiley

    Dr Per Borghammer

  86. Positron emission tomography visualized stimulation of the vestibular organ is localized in Heschl's gyrus

    Article • Human Brain Mapping, September 2019, Wiley

    Dr Per Borghammer

  87. 18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma

    Article • Clinical Nuclear Medicine, August 2019, Wolters Kluwer Health

    Dr Per Borghammer

  88. Engineered antibodies: new possibilities for brain PET?

    Article • European Journal of Pediatrics, July 2019, Springer Science + Business Media

    Dr Per Borghammer

  89. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats

    Article • Acta Neuropathologica, June 2019, Springer Science + Business Media

    Dr Per Borghammer

  90. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas

    Article • Clinical Nuclear Medicine, May 2019, Wolters Kluwer Health

    Dr Per Borghammer

  91. Cardiac 11C-Donepezil Binding Increases With Age in Healthy Humans: Potentially Signifying Sigma-1 Receptor Upregulation

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, March 2019, SAGE Publications

    Dr Per Borghammer

  92. The Gut and Parkinson’s Disease: Hype or Hope?

    Article • Journal of Parkinson’s Disease, December 2018, IOS Press

    Dr Per Borghammer

  93. Imaging the Autonomic Nervous System in Parkinson’s Disease

    Article • Current Neurology and Neuroscience Reports, September 2018, Springer Science + Business Media

    Dr Per Borghammer

  94. Evaluation of Active Brown Adipose Tissue by the Use of Hyperpolarized [1-13C]Pyruvate MRI in Mice

    Article • International Journal of Molecular Sciences, September 2018, MDPI AG

    Steen B. Pedersen, Dr Per Borghammer

  95. Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study

    Article • Neurobiology of Disease, September 2018, Elsevier

    Dr Per Borghammer

  96. Objective intestinal function in patients with idiopathic REM sleep behavior disorder

    Article • Parkinsonism & Related Disorders, August 2018, Elsevier

    Dr Per Borghammer

  97. Is constipation in Parkinson's disease caused by gut or brain pathology?

    Article • Parkinsonism & Related Disorders, August 2018, Elsevier

    Dr Per Borghammer

  98. The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer’s Disease

    Article • International Journal of Alzheimer s Disease, July 2018, Hindawi Publishing Corporation

    Dr Per Borghammer

  99. Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder

    Article • Neurobiology of Disease, July 2018, Elsevier

    Dr Per Borghammer

  100. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study

    Article • The Lancet Neurology, July 2018, Elsevier

    Dr Per Borghammer

  101. Preclinical evaluation of potential infection-imaging probe [68 Ga]Ga-DOTA-K-A9 in sterile and infectious inflammation

    Article • Journal of Labelled Compounds, June 2018, Wiley

    Dr Per Borghammer

  102. Gastrointestinal transit time and heart rate variability in patients with mild acquired brain injury

    Article • PeerJ, June 2018, PeerJ

    Dr Per Borghammer

  103. Gastric emptying in Parkinson's disease – A mini-review

    Article • Parkinsonism & Related Disorders, June 2018, Elsevier

    Dr Per Borghammer

  104. Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients

    Article • Movement Disorders, May 2018, Wiley

    Dr Per Borghammer

  105. F26. Automated chin EMG analysis for quantification of REM sleep without atonia

    Article • Clinical Neurophysiology, May 2018, Elsevier

    Dr Per Borghammer

  106. Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm

    Article • Clinical Neurophysiology, March 2018, Elsevier

    Dr Per Borghammer

  107. Molecular Imaging of the Noradrenergic System in Idiopathic Parkinson's Disease

    Article • January 2018, Elsevier

    Dr Per Borghammer

  108. Evaluation of the noradrenergic system in Parkinson’s disease: an 11C-MeNER PET and neuromelanin MRI study

    Article • Brain, December 2017, Oxford University Press (OUP)

    Dr Per Borghammer, Malene Flensborg Damholdt

  109. Multimodal 18 F-Fluciclovine PET/MRI and Ultrasound-Guided Neurosurgery of an Anaplastic Oligodendroglioma

    Article • World Neurosurgery, December 2017, Elsevier

    Dr Per Borghammer

  110. Tonsillectomy and risk of Parkinson's disease: A danish nationwide population-based cohort study

    Article • Movement Disorders, November 2017, Wiley

    MD Morten G Stokholm, Dr Per Borghammer

  111. MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding

    Article • Molecular Imaging and Biology, November 2017, Springer Science + Business Media

    Dr Per Borghammer

  112. Pancreatic Polypeptide in Parkinson’s Disease: A Potential Marker of Parasympathetic Denervation

    Article • Journal of Parkinson’s Disease, November 2017, IOS Press

    Dr Per Borghammer

  113. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study

    Article • The Lancet Neurology, October 2017, Elsevier

    Dr Per Borghammer

  114. Noradrenergic Deficits in Parkinson Disease Imaged with 11C-MeNER

    Article • Journal of Nuclear Medicine, August 2017, Society of Nuclear Medicine

    Dr Per Borghammer, Malene Flensborg Damholdt

  115. How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology

    Article • Movement Disorders, August 2017, Wiley

    Dr Per Borghammer

  116. Gastrointestinal Transit Time in Parkinson’s Disease Using a Magnetic Tracking System

    Article • Journal of Parkinson’s Disease, August 2017, IOS Press

    Dr Per Borghammer

  117. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease

    Article • Brain, May 2017, Oxford University Press (OUP)

    Dr Per Borghammer

  118. Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson’s Disease: A Colon Transit and Volume Study

    Article • Journal of Parkinson’s Disease, May 2017, IOS Press

    Dr Per Borghammer

  119. Preventing Parkinson disease by vagotomy

    Article • Neurology, April 2017, Wolters Kluwer Health

    Dr Per Borghammer

  120. Imaging Parkinson’s disease below the neck

    Article • npj Parkinson s Disease, April 2017, Springer Science + Business Media

    Dr Per Borghammer

  121. Reply to the letter to the Editor: Comment to Barichella and colleagues

    Article • Movement Disorders, April 2017, Wiley

    Dr Per Borghammer

  122. In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography

    Article • Movement Disorders, March 2017, Wiley

    Dr Per Borghammer, Malene Flensborg Damholdt

  123. Functional image-guided dose escalation in gliomas using of state-of-the-art photon vs. proton therapy

    Article • Acta Oncologica, February 2017, Taylor & Francis

    Dr Per Borghammer

  124. Decreased intestinal acetylcholinesterase in early Parkinson disease

    Article • Neurology, January 2017, Wolters Kluwer Health

    Dr Per Borghammer

  125. Kinetic Modelling of Infection Tracers [18F]FDG, [68Ga]Ga-Citrate, [11C]Methionine, and [11C]Donepezil in a Porcine Osteomyelitis Model

    Article • Contrast Media & Molecular Imaging, January 2017, Hindawi Publishing Corporation

    Dr Per Borghammer

  126. Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives

    Article • Movement Disorders, November 2016, Wiley

    Dr Per Borghammer

  127. Cholinergic PET imaging in infections and inflammation using 11C-donepezil and 18F-FEOBV

    Article • European Journal of Pediatrics, October 2016, Springer Science + Business Media

    Dr Per Borghammer

  128. Appendectomy and risk of Parkinson's disease: A nationwide cohort study with more than 10 years of follow-up

    Article • Movement Disorders, September 2016, Wiley

    Dr Per Borghammer

  129. Constipation and risk of Parkinson’s disease: A Danish population-based cohort study

    Article • Parkinsonism & Related Disorders, July 2016, Elsevier

    Dr Per Borghammer

  130. Vagotomy and subsequent development of diabetes – A nested case–control study

    Article • Metabolism, July 2016, Elsevier

    Dr Per Borghammer

  131. A dual tracer 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT pilot study for detection of cardiac sarcoidosis

    Article • EJNMMI Research, June 2016, Springer Science + Business Media

    Dr Per Borghammer

  132. In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET

    Article • Brain, May 2016, Oxford University Press (OUP)

    Dr Per Borghammer

  133. Imaging Systemic Dysfunction in Parkinson’s Disease

    Article • Current Neurology and Neuroscience Reports, April 2016, Springer Science + Business Media

    Dr Per Borghammer

  134. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients

    Article • Annals of Neurology, April 2016, Wiley

    MD Morten G Stokholm, Dr Per Borghammer

  135. Sex differences of human cortical blood flow and energy metabolism

    Article • Journal of Cerebral Blood Flow & Metabolism, January 2016, SAGE Publications

    Dr Per Borghammer

  136. Does vagotomy reduce the risk of Parkinson's disease: The authors reply

    Article • Annals of Neurology, November 2015, Wiley

    Dr Per Borghammer

  137. Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI

    Article • Nuclear Medicine Communications, November 2015, Wolters Kluwer Health

    Dr Per Borghammer

  138. EANM’15

    Article • European Journal of Pediatrics, October 2015, Springer Science + Business Media

    Dr Per Borghammer

  139. Reply

    Article • Annals of Neurology, September 2015, Wiley

    Dr Per Borghammer

  140. Pseudoprogression after proton radiotherapy for pediatric low grade glioma

    Article • Acta Oncologica, September 2015, Informa Healthcare

    Dr Per Borghammer

  141. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging

    Article • Acta Radiologica, September 2015, SAGE Publications

    Dr Per Borghammer

  142. Molecular imaging of cholinergic processes in prostate cancer using 11C-donepezil and 18F-FEOBV

    Article • European Journal of Pediatrics, August 2015, Springer Science + Business Media

    Dr Per Borghammer

  143. Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease

    Article • Brain, July 2015, Oxford University Press (OUP)

    Dr Per Borghammer

  144. Vagotomy and subsequent risk of Parkinson's disease

    Article • Annals of Neurology, July 2015, Wiley

    Dr Per Borghammer

  145. Olfactory function in Parkinson's Disease - effects of training

    Article • Acta Neurologica Scandinavica, April 2015, Wiley

    Dr Per Borghammer, Malene Flensborg Damholdt

  146. Salivary Acetylcholinesterase Activity Is Increased in Parkinson’s Disease: A Potential Marker of Parasympathetic Dysfunction

    Article • Parkinson s Disease, January 2015, Hindawi Publishing Corporation

    Dr Per Borghammer

  147. Imaging the parasympathetic nervous system in Parkinson's disease

    Article • Brain, December 2014, Oxford University Press (OUP)

    Dr Per Borghammer

  148. In Vivo Imaging of Human Acetylcholinesterase Density in Peripheral Organs Using 11C-Donepezil: Dosimetry, Biodistribution, and Kinetic Analyses

    Article • Journal of Nuclear Medicine, October 2014, Society of Nuclear Medicine

    Dr Per Borghammer

  149. Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders

    Article • International Journal of Clinical Practice, April 2014, Wiley

    Dr Per Borghammer

  150. False-Positive 123I-FP-CIT Scintigraphy and Suggested Dopamine Transporter Upregulation Due to Chronic Modafinil Treatment

    Article • Clinical Nuclear Medicine, January 2014, Wolters Kluwer Health

    Dr Per Borghammer

  151. Brain Energy Metabolism and Blood Flow Differences in Healthy Aging

    Article • Journal of Cerebral Blood Flow & Metabolism, February 2012, SAGE Publications

    Dr Per Borghammer

  152. Cerebral oxygen metabolism in patients with early Parkinson's disease

    Article • Journal of the Neurological Sciences, February 2012, Elsevier

    Dr Per Borghammer

  153. Clinical heterogeneity in Parkinson’s disease revisited: a latent profile analysis

    Article • Acta Neurologica Scandinavica, June 2011, Wiley

    Dr Per Borghammer, Malene Flensborg Damholdt

  154. Glucose metabolism in small subcortical structures in Parkinson’s disease

    Article • Acta Neurologica Scandinavica, June 2011, Wiley

    Dr Per Borghammer

  155. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance

    Article • Movement Disorders, June 2011, Wiley

    Dr Per Borghammer, Malene Flensborg Damholdt

  156. The Parkinsonian Personality and Concomitant Depression

    Article • Journal of Neuropsychiatry, February 2011, American Psychiatric Association

    Dr Per Borghammer, Malene Flensborg Damholdt

  157. Molecular Imaging and the Neuropathologies of Parkinson’s Disease

    Article • January 2011, Springer Science + Business Media

    Dr Per Borghammer

  158. Variable ATP Yields and Uncoupling of Oxygen Consumption in Human Brain

    Article • January 2011, Springer Science + Business Media

    Dr Per Borghammer

  159. Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

    Article • Brain Structure and Function, April 2010, Springer Science + Business Media

    Dr Per Borghammer

  160. Partial volume correction using cortical surfaces

    Article • March 2010, SPIE

    Dr Per Borghammer

  161. Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study

    Article • Neurobiology of Aging, March 2010, Elsevier

    Dr Per Borghammer

  162. A deformation-based morphometry study of patients with early-stage Parkinson’s disease

    Article • European Journal of Neurology, November 2009, Wiley

    Dr Per Borghammer

  163. Subcortical elevation of metabolism in Parkinson's disease — A critical reappraisal in the context of global mean normalization

    Article • NeuroImage, October 2009, Elsevier

    Dr Per Borghammer

  164. Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization

    Article • NeuroImage, July 2009, Elsevier

    Dr Per Borghammer

  165. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease

    Article • NeuroImage, April 2009, Elsevier

    Dr Per Borghammer

  166. Low Cerebral Oxygen Consumption and Blood Flow in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy

    Article • Gastroenterology, March 2009, Elsevier

    Dr Per Borghammer

  167. Improvement of brain tissue oxygenation by inhalation of carbogen

    Article • Neuroscience, October 2008, Elsevier

    Dr Per Borghammer

  168. Effect of memantine on CBF and CMRO2in patients with early Parkinson’s disease

    Article • Acta Neurologica Scandinavica, May 2008, Wiley

    Dr Per Borghammer

  169. Normalization in PET group comparison studies—The importance of a valid reference region

    Article • NeuroImage, April 2008, Elsevier

    Dr Per Borghammer

  170. Fluorodopa F 18 Positron Emission Tomography and the Progression of Parkinson Disease

    Article • Archives of Neurology, September 2005, American Medical Association (AMA)

    Dr Per Borghammer